Literature DB >> 2861296

Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus).

R Yanagihara, H L Amyx, D C Gajdusek.   

Abstract

Subclinical chronic infections characterized by transient viremia, prolonged virus shedding in oropharyngeal secretions and feces, and virus persistence in tissues (particularly lung) developed in laboratory-bred weanling bank voles (Clethrionomys glareolus) inoculated intramuscularly with Puumala virus (strain Hällnäs), the etiologic agent of nephropathia epidemica. Viral antigen, as evidence by granular fluorescence, was detected in the lungs, liver, spleen, pancreas, salivary glands, and small intestine. Infectious virus was found in the lungs from 14 to 270 days postinoculation, and feces and urine collected 35 to 130 days postinoculation were regularly and sporadically infectious, respectively. Horizontal transmission coincided with virus shedding in oropharyngeal secretions. Suckling voles also developed asymptomatic persistent infections after intracerebral inoculation, and histopathological changes were absent despite widespread infection. Our data resemble findings in Apodemus agrarius experimentally infected with Hantaan virus, the prototype virus of hemorrhagic fever with renal syndrome, suggesting that the mechanisms of maintenance and transmission of Puumala and Hantaan viruses are similar in their respective wild-rodent hosts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861296      PMCID: PMC254894     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  [Nephropathia epidemica. 12 cases from Grane and Hattfjelldal in Nordland county August 1973-January 1974].

Authors:  G Mouland
Journal:  Tidsskr Nor Laegeforen       Date:  1975-03-10

2.  Incidence and prevalence of endemic benign (epidemic) nephropathy in AC county, Sweden, in relation to population density and prevalence of small rodents.

Authors:  K Nyström
Journal:  Acta Med Scand Suppl       Date:  1977

3.  Isolation of the etiologic agent of Korean Hemorrhagic fever.

Authors:  H W Lee; P W Lee; K M Johnson
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

4.  Nephropathia epidemica in Finland. A clinical histological and epidemiological study.

Authors:  J Lähdevirta
Journal:  Ann Clin Res       Date:  1971

5.  HFRS antigen and antibody in two species of Swedish voles.

Authors:  P W Lee; A Svedmyr; H L Amyx; D C Gajdusek; C J Gibbs; O Löfgren; K Nyström
Journal:  Scand J Infect Dis       Date:  1982

6.  The role of small rodents and patterns of living in the epidemiology of nephropathia epidemica.

Authors:  H Korpela; J Lähdevirta
Journal:  Scand J Infect Dis       Date:  1978

7.  Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats.

Authors:  H W Lee; L J Baek; K M Johnson
Journal:  J Infect Dis       Date:  1982-11       Impact factor: 5.226

8.  Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius.

Authors:  H W Lee; P W Lee; L J Baek; C K Song; I W Seong
Journal:  Am J Trop Med Hyg       Date:  1981-09       Impact factor: 2.345

9.  Features of circulation of hemorrhagic fever with renal syndrome (HFRS) virus among small mammals in the European U.S.S.R.

Authors:  I N Gavrilovskaya; N S Apekina; A D Bernshtein; E V Ryltseva; E A Gorbachkova; M P Chumakov
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

10.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

View more
  72 in total

1.  Accumulation of terminally deleted RNAs may play a role in Seoul virus persistence.

Authors:  B J Meyer; C Schmaljohn
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Pathology of Black Creek Canal virus infection in juvenile hispid cotton rats (Sigmodon hispidus).

Authors:  Adrian N Billings; Pierre E Rollin; Mary L Milazzo; Claudia P Molina; Eduardo J Eyzaguirre; Walter Livingstone; Thomas G Ksiazek; Charles F Fulhorst
Journal:  Vector Borne Zoonotic Dis       Date:  2010-08       Impact factor: 2.133

Review 3.  The Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  David Safronetz; Hideki Ebihara; Heinz Feldmann; Jay W Hooper
Journal:  Antiviral Res       Date:  2012-06-15       Impact factor: 5.970

4.  Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses.

Authors:  R Yanagihara; D J Silverman
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 5.  Emerging infectious diseases: the Bunyaviridae.

Authors:  Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

Review 6.  The role of mites in the transmission and maintenance of Hantaan virus (Hantavirus: Bunyaviridae).

Authors:  Xue-jie Yu; Robert B Tesh
Journal:  J Infect Dis       Date:  2014-06-23       Impact factor: 5.226

7.  Protection against hantavirus infection by dam's immunity transferred vertically to neonates.

Authors:  K Dohmae; Y Nishimune
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  Pathogenesis of experimental Hantaan virus infection in laboratory rats.

Authors:  P W Lee; R Yanagihara; C J Gibbs; D C Gajdusek
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  Seasonal dispersal patterns of sylvan deer mice (Peromyscus maniculatus) within Montana rangelands.

Authors:  Dean Waltee; Brent N Lonner; Amy J Kuenzi; Richard J Douglass
Journal:  J Wildl Dis       Date:  2009-10       Impact factor: 1.535

10.  IgG avidity assay for estimation of the time after onset of hantavirus infection in colonized and wild bank voles.

Authors:  I Gavrilovskaya; N Apekina; N Okulova; V Demina; A Bernshtein; Y Myasnikov
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.